AI assistant
Sending…
Traws Pharma, Inc. — Director's Dealing 2024
Sep 17, 2024
35199_dirs_2024-09-17_0dd65ffc-b00a-4894-8691-a6b5c2495841.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Traws Pharma, Inc. (TRAW)
CIK: 0001130598
Period of Report: 2024-09-16
Reporting Person: Greenwood Luba (N/A)
More from Traws Pharma, Inc.
Annual Report
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Share Issue/Capital Change
2026
May 22
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 8